February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Naveen Pemmaraju: Honored to deliver lecture on BPDCN to our MD Anderson Cancer Center Heme/Onc Fellows!
Nov 30, 2023, 13:23

Naveen Pemmaraju: Honored to deliver lecture on BPDCN to our MD Anderson Cancer Center Heme/Onc Fellows!

Naveen Pemmaraju, made the following post on Twitter:

“Honored to deliver lecture on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) to our MD Anderson Cancer Center
Heme/Onc Fellows! Thanks for the kind invitation and great discussion!”

Source: Naveen Pemmaraju/Twitter

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML. He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.